Corrigendum: Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma

Front Med (Lausanne). 2023 Jul 10:10:1244638. doi: 10.3389/fmed.2023.1244638. eCollection 2023.

Authors

Hanwen Lu^#^{1

2}, Liwei Zhou^#^{1

3}, Bingchang Zhang^{1

3}, Yuanyuan Xie^{1

3}, Huiyin Yang^{1

2}, Zhanxiang Wang^{1

2

3}

Affiliations

¹ Department of Neurosurgery, Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
² Department of Neuroscience, Institute of Neurosurgery, School of Medicine, Xiamen University, Xiamen, China.
³ Department of Neurosurgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.3389/fmed.2022.939776.].

Keywords: Cuproptosis; glioma; immune infiltration; lipoylation; prognostic biomarker.

Copyright © 2023 Lu, Zhou, Zhang, Xie, Yang and Wang.

Publication types

Published Erratum